Integrated And Flexible Temperature-Controlled Supply Chain Solutions For The Life Sciences

By Dave Wilson, Vice President EMEA, Cryoport Systems

Biotech companies continue to innovate cutting-edge therapeutics, and the companies that support their efforts continue to strive for best practices as these new therapies advance and evolve. In the field of advanced therapy logistics, a risk-averse culture with a zero-failure tolerance mindset sits at the heart of innovative thinking and a dedication to always improving.

As the industry around cell and gene therapy solutions grows, logistics service providers are becoming directly connected to the patients. The hope supplied by these new advanced therapies rely completely on a complex process supply chain upon which every link in the chain must hold strong.